These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 32220865)

  • 21. Famotidine Against SARS-CoV2: A Hope or Hype?
    Ghosh R; Chatterjee S; Dubey S; Lavie CJ
    Mayo Clin Proc; 2020 Aug; 95(8):1797-1799. PubMed ID: 32753153
    [No Abstract]   [Full Text] [Related]  

  • 22. Existing Drugs Might Treat COVID-19.
    Abbasi J
    JAMA; 2020 Jun; 323(22):2239. PubMed ID: 32515802
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of Potential Therapeutic Options for COVID-19.
    Austin D; Okour M
    J Clin Pharmacol; 2020 Aug; 60(8):976-977. PubMed ID: 32469418
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacokinetics of Lopinavir and Ritonavir in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19).
    Schoergenhofer C; Jilma B; Stimpfl T; Karolyi M; Zoufaly A
    Ann Intern Med; 2020 Oct; 173(8):670-672. PubMed ID: 32422065
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug researchers pursue new lines of attack against COVID-19.
    Harrison C
    Nat Biotechnol; 2020 Jun; 38(6):659-662. PubMed ID: 32417850
    [No Abstract]   [Full Text] [Related]  

  • 26. Psychiatric implications of the use of hydroxychloroquine in COVID-19 patients.
    Rani S; Grover S; Mehra A; Sahoo S
    Indian J Pharmacol; 2020; 52(3):229-231. PubMed ID: 32874009
    [No Abstract]   [Full Text] [Related]  

  • 27. Anticoagulation in COVID-19.
    Atallah B; Mallah SI; AlMahmeed W
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(4):260-261. PubMed ID: 32352517
    [No Abstract]   [Full Text] [Related]  

  • 28. Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine.
    Sahraei Z; Shabani M; Shokouhi S; Saffaei A
    Int J Antimicrob Agents; 2020 Apr; 55(4):105945. PubMed ID: 32194152
    [No Abstract]   [Full Text] [Related]  

  • 29. Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19.
    Gevers S; Kwa MSG; Wijnans E; van Nieuwkoop C
    Clin Microbiol Infect; 2020 Sep; 26(9):1276-1277. PubMed ID: 32422406
    [No Abstract]   [Full Text] [Related]  

  • 30. Statin therapy and SAR-COV-2: an available and potential therapy?
    Abdel-Latif RG; Mohammed S; Elgendy IY
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):333-334. PubMed ID: 32379307
    [No Abstract]   [Full Text] [Related]  

  • 31. Favipiravir, an antiviral for COVID-19?
    Coomes EA; Haghbayan H
    J Antimicrob Chemother; 2020 Jul; 75(7):2013-2014. PubMed ID: 32417899
    [No Abstract]   [Full Text] [Related]  

  • 32. Covid-19-The real role of NSAIDs in Italy.
    de Girolamo L; Peretti GM; Maffulli N; Brini AT
    J Orthop Surg Res; 2020 May; 15(1):165. PubMed ID: 32366317
    [No Abstract]   [Full Text] [Related]  

  • 33. Audio Interview: Tocilizumab and Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Oct; 383(17):e114. PubMed ID: 33085870
    [No Abstract]   [Full Text] [Related]  

  • 34. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease.
    Richardson P; Griffin I; Tucker C; Smith D; Oechsle O; Phelan A; Rawling M; Savory E; Stebbing J
    Lancet; 2020 Feb; 395(10223):e30-e31. PubMed ID: 32032529
    [No Abstract]   [Full Text] [Related]  

  • 35. Inflammatory Bowel Diseases and Biological Treatment in SARS-CoV-2 Era. Why Not?
    Grassia R; Soro S; Conti CB
    Inflamm Bowel Dis; 2020 Jun; 26(7):e71. PubMed ID: 32386056
    [No Abstract]   [Full Text] [Related]  

  • 36. d-Dimer and COVID-19.
    Oudkerk M; Büller HR; Kuijpers D; Oudkerk SF; van Beek EJR
    Radiology; 2020 Dec; 297(3):E343-E344. PubMed ID: 33048037
    [No Abstract]   [Full Text] [Related]  

  • 37. Discovering drugs to treat coronavirus disease 2019 (COVID-19).
    Dong L; Hu S; Gao J
    Drug Discov Ther; 2020; 14(1):58-60. PubMed ID: 32147628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chloroquine and Hydroxychloroquine in COVID-19: Challenges and the Need for Caution in Low-Resource Settings.
    Islam M
    J Coll Physicians Surg Pak; 2020 Jun; 30(6):78. PubMed ID: 32723461
    [No Abstract]   [Full Text] [Related]  

  • 39. Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic.
    South AM; Tomlinson L; Edmonston D; Hiremath S; Sparks MA
    Nat Rev Nephrol; 2020 Jun; 16(6):305-307. PubMed ID: 32246101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sofosbuvir as a potential option for the treatment of COVID-19.
    Nourian A; Khalili H
    Acta Biomed; 2020 May; 91(2):236-238. PubMed ID: 32420958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.